Anxiolytic ß-carbolines: from molecular biology to the clinic
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Berlin [u.a.]
Springer
1993
|
| Schriftenreihe: | Psychopharmacology
11 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | X, 151 S. Ill., graph. Darst. |
| ISBN: | 3540571442 0387571442 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010269914 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 950626s1993 ad|| |||| 00||| eng d | ||
| 020 | |a 3540571442 |9 3-540-57144-2 | ||
| 020 | |a 0387571442 |9 0-387-57144-2 | ||
| 035 | |a (OCoLC)28966403 | ||
| 035 | |a (DE-599)BVBBV010269914 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 | ||
| 050 | 0 | |a RM666.A12 | |
| 082 | 0 | |a 615/.7882 |2 20 | |
| 245 | 1 | 0 | |a Anxiolytic ß-carbolines |b from molecular biology to the clinic |c ed. David N. Stephens |
| 264 | 1 | |a Berlin [u.a.] |b Springer |c 1993 | |
| 300 | |a X, 151 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Psychopharmacology |v 11 | |
| 500 | |a Literaturangaben | ||
| 650 | 4 | |a Mental disorders - Drug therapy | |
| 650 | 7 | |a Antidepressivos (Farmacologia) |2 larpcal | |
| 650 | 4 | |a Abecarnil |x Testing | |
| 650 | 4 | |a Anti-Anxiety Agents |x pharmacokinetics |v Congresses | |
| 650 | 4 | |a Benzodiazepines |x pharmacokinetics |v Congresses | |
| 650 | 4 | |a Carbolines |x Therapeutic use |x Testing | |
| 650 | 4 | |a Carbolines |x therapeutic use |v Congresses | |
| 650 | 4 | |a Drug Evaluation |v Congresses | |
| 650 | 4 | |a GABA |x Agonists |x Therapeutic use |x Testing | |
| 650 | 4 | |a Receptors, GABA-A |v Congresses | |
| 650 | 4 | |a Tranquilizing drugs |x Mechanism of action | |
| 650 | 0 | 7 | |a Abecarnil |0 (DE-588)4331762-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Abecarnil |0 (DE-588)4331762-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Stephens, David N. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006831721 | ||
Datensatz im Suchindex
| _version_ | 1804124684092964864 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010269914 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.A12 |
| callnumber-search | RM666.A12 |
| callnumber-sort | RM 3666 A12 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)28966403 (DE-599)BVBBV010269914 |
| dewey-full | 615/.7882 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7882 |
| dewey-search | 615/.7882 |
| dewey-sort | 3615 47882 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01758nam a2200505 cb4500</leader><controlfield tag="001">BV010269914</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950626s1993 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540571442</subfield><subfield code="9">3-540-57144-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0387571442</subfield><subfield code="9">0-387-57144-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28966403</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010269914</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.A12</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7882</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anxiolytic ß-carbolines</subfield><subfield code="b">from molecular biology to the clinic</subfield><subfield code="c">ed. David N. Stephens</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 151 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Psychopharmacology</subfield><subfield code="v">11</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental disorders - Drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antidepressivos (Farmacologia)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Abecarnil</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Anxiety Agents</subfield><subfield code="x">pharmacokinetics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzodiazepines</subfield><subfield code="x">pharmacokinetics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbolines</subfield><subfield code="x">Therapeutic use</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbolines</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GABA</subfield><subfield code="x">Agonists</subfield><subfield code="x">Therapeutic use</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, GABA-A</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tranquilizing drugs</subfield><subfield code="x">Mechanism of action</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Abecarnil</subfield><subfield code="0">(DE-588)4331762-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Abecarnil</subfield><subfield code="0">(DE-588)4331762-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stephens, David N.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006831721</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV010269914 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:49:34Z |
| institution | BVB |
| isbn | 3540571442 0387571442 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006831721 |
| oclc_num | 28966403 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | X, 151 S. Ill., graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer |
| record_format | marc |
| series2 | Psychopharmacology |
| spelling | Anxiolytic ß-carbolines from molecular biology to the clinic ed. David N. Stephens Berlin [u.a.] Springer 1993 X, 151 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Psychopharmacology 11 Literaturangaben Mental disorders - Drug therapy Antidepressivos (Farmacologia) larpcal Abecarnil Testing Anti-Anxiety Agents pharmacokinetics Congresses Benzodiazepines pharmacokinetics Congresses Carbolines Therapeutic use Testing Carbolines therapeutic use Congresses Drug Evaluation Congresses GABA Agonists Therapeutic use Testing Receptors, GABA-A Congresses Tranquilizing drugs Mechanism of action Abecarnil (DE-588)4331762-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Abecarnil (DE-588)4331762-5 s DE-604 Stephens, David N. Sonstige oth |
| spellingShingle | Anxiolytic ß-carbolines from molecular biology to the clinic Mental disorders - Drug therapy Antidepressivos (Farmacologia) larpcal Abecarnil Testing Anti-Anxiety Agents pharmacokinetics Congresses Benzodiazepines pharmacokinetics Congresses Carbolines Therapeutic use Testing Carbolines therapeutic use Congresses Drug Evaluation Congresses GABA Agonists Therapeutic use Testing Receptors, GABA-A Congresses Tranquilizing drugs Mechanism of action Abecarnil (DE-588)4331762-5 gnd |
| subject_GND | (DE-588)4331762-5 (DE-588)1071861417 |
| title | Anxiolytic ß-carbolines from molecular biology to the clinic |
| title_auth | Anxiolytic ß-carbolines from molecular biology to the clinic |
| title_exact_search | Anxiolytic ß-carbolines from molecular biology to the clinic |
| title_full | Anxiolytic ß-carbolines from molecular biology to the clinic ed. David N. Stephens |
| title_fullStr | Anxiolytic ß-carbolines from molecular biology to the clinic ed. David N. Stephens |
| title_full_unstemmed | Anxiolytic ß-carbolines from molecular biology to the clinic ed. David N. Stephens |
| title_short | Anxiolytic ß-carbolines |
| title_sort | anxiolytic ß carbolines from molecular biology to the clinic |
| title_sub | from molecular biology to the clinic |
| topic | Mental disorders - Drug therapy Antidepressivos (Farmacologia) larpcal Abecarnil Testing Anti-Anxiety Agents pharmacokinetics Congresses Benzodiazepines pharmacokinetics Congresses Carbolines Therapeutic use Testing Carbolines therapeutic use Congresses Drug Evaluation Congresses GABA Agonists Therapeutic use Testing Receptors, GABA-A Congresses Tranquilizing drugs Mechanism of action Abecarnil (DE-588)4331762-5 gnd |
| topic_facet | Mental disorders - Drug therapy Antidepressivos (Farmacologia) Abecarnil Testing Anti-Anxiety Agents pharmacokinetics Congresses Benzodiazepines pharmacokinetics Congresses Carbolines Therapeutic use Testing Carbolines therapeutic use Congresses Drug Evaluation Congresses GABA Agonists Therapeutic use Testing Receptors, GABA-A Congresses Tranquilizing drugs Mechanism of action Abecarnil Konferenzschrift |
| work_keys_str_mv | AT stephensdavidn anxiolyticßcarbolinesfrommolecularbiologytotheclinic |